INNOVIVA INC (INVA) — insider trading
Health Care · NASDAQ
INNOVIVA INC (INVA) has 22 reported SEC Form 4 insider transactions in our data (latest 2026-05-20).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Zhen Marianne | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 1,127 | $22.24 | $25.1K | Form 4 |
| 2026-05-20 | Raifeld Pavel | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 1,130 | $22.24 | $25.1K | Form 4 |
| 2026-05-20 | Basso Stephen | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 559 | $22.24 | $12.4K | Form 4 |
| 2026-05-18 | Linden Josephine | Director | Grant / award / vesting (derivative) | 9,166 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Linden Josephine | Director | Grant / award / vesting | 9,461 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Linden Josephine | Director | Grant / award / vesting | 5,733 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Raifeld Pavel | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 1,123 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Basso Stephen | Officer (Chief Financial Officer) | Grant / award / vesting | 1,123 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Haimovitz Jules | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Haimovitz Jules | Director | Grant / award / vesting | 9,786 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Small Derek A | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Small Derek A | Director | Grant / award / vesting | 9,786 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Basso Stephen | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 93,750 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Basso Stephen | Officer (Chief Financial Officer) | Grant / award / vesting | 37,994 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Schlesinger Sarah J. | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Schlesinger Sarah J. | Director | Grant / award / vesting | 9,786 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Zhen Marianne | Officer (Chief Accounting Officer) | Grant / award / vesting (derivative) | 31,500 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Zhen Marianne | Officer (Chief Accounting Officer) | Grant / award / vesting | 12,766 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Raifeld Pavel | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 312,500 | $0.00 | $0 | Form 4 |
| 2026-05-04 | Raifeld Pavel | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 126,646 | $0.00 | $0 | Form 4 |
| 2026-05-04 | DiPaolo Mark | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-05-04 | DiPaolo Mark | Director | Grant / award / vesting | 9,786 | $0.00 | $0 | Form 4 |
Ask the chat about INVA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: INNOVIVA INC (INVA).
Last updated 2026-05-20 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.